Our Take
India's healthcare data advantage is being squandered: private hospitals treat the majority of patients but produce almost no clinical evidence, leaving the field entirely to teaching hospitals.
Why it matters
India ranks ninth globally in research impact despite fourth-place publication volume. This gap reflects a structural problem: the institutions closest to patient outcomes have no incentive to document them. For policymakers, it signals wasted epidemiological intelligence. For researchers, it means clinical insights from 60% of the healthcare system are locked away.
Do this week
Healthcare IT leaders: audit your hospital's data governance and publication pipeline this quarter so you can identify which clinical datasets could support publishable research without commercial conflict.
Private hospitals in India publish minimal research despite dominant market share
A study published in the Journal of Medical Evidence (BMJ group) analyzed research output across Indian hospitals from January 2021 to December 2025, measured by publications indexed in Scopus, PubMed, and Google Scholar. The gap between hospital types is stark.
Top 50 private hospitals without medical colleges attached averaged 242 publications across the five-year period. Top 50 Indian hospitals with medical colleges averaged 1,530 publications. AIIMS Delhi led at 6,932 publications, followed by CMC Vellore at 5,333 (per the study).
Nearly all hospitals without medical colleges produced fewer than 10 publications annually. In absolute terms, Mayo Clinic alone generates 8,000 papers per year, more than the entire Indian private sector combined.
The imbalance matters because private institutions handle approximately 60% of patient volume in India, according to the study. The data generated at those institutions remains largely undocumented.
India lags peers in both volume and impact
Comparative benchmarks show the wider problem. Top medical schools in China average over 16,000 publications across the same period, with Shanghai Jiao Tong and Peking University leading. The US averages nearly 14,500 (Harvard and Johns Hopkins top the list), and the UK averages 13,500 (Oxford and UCL lead), per the study.
India's researchers produce the fourth-highest volume of publications globally after the US, China, and UK. But citation impact ranks ninth. The study authors, Dr. Samiran Nundy and Dr. Parmanand Tiwari from Sir Ganga Ram Hospital in Delhi, attributed this discrepancy to quality gaps: "Papers are not referred to and do not make a major impact on the world stage."
Commercial priorities eclipse clinical evidence generation
The study identifies the root cause directly: "Indian healthcare is now dominated by private hospitals many of which are controlled by large corporate houses whose main purpose is making a profit for its shareholders, so education and research is not a priority."
This creates a structural incentive misalignment. Private hospitals optimize for throughput and revenue, not publication. They lack both the financial motivation and, often, the electronic infrastructure to support research workflows. The authors note that absent incentives, missing hardware, and commercial-first priorities explain the output collapse.
The consequence is epidemiological silence. Clinical patterns, treatment outcomes, and disease incidence observed in 60% of India's hospitals leave no published record. That data could inform public health policy, train the next generation of physicians, and contribute to global understanding of disease burden in South Asia. Instead, it stays proprietary.
What hospital leaders and researchers should do
For hospital administrators: audit your current publication pipeline and ask whether commercial confidentiality genuinely requires silence on clinical outcomes. Many private hospitals could carve out anonymized datasets for research without exposing proprietary operations.
For clinical teams: establish internal mechanisms to identify publishable findings within your patient cohorts. A single clinician-led review of discharge data, complication rates, or treatment efficacy requires no additional patient burden and produces institutional knowledge.
For IT and data governance: build infrastructure that separates operational data (billing, operations, marketing) from clinical data that could support publication. This is not free, but the cost of inaction is visibility zero.
For researchers outside private hospitals: recognize that partnering with private institutions on outcomes research is now the fastest way to access India's largest clinical datasets. Propose formal collaboration agreements that guarantee publication rights.